KL7016
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KL7016, covering 2017-12-21 to 2017-12-21. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye Syndrome [Phase 2]